Company intelligence / Profile preview

InnoFluidics

Eindhoven, North Brabant, Netherlandsinnofluidics.com ↗

Ownership: Private
Development stage: Preclinical

Overview

InnoFluidics has developed a proprietary microfluidic platform enabling fast, sensitive, label-free detection and collection of circulating tumor cells from blood. The company’s approach allows direct measurement of cellular biophysical properties for applications in cancer diagnostics, drug response monitoring, and bioprocess optimization. No published clinical results yet; the company appears to be at the advanced prototype or validation stage.

Therapeutic areas: OncologyOther
Modalities: Label-free cell analysisMicrofluidic-based rare cell sortingElectrical impedance cytometryLiquid biopsy platforms
Industry: Pathology

Beyond the preview

Go deeper on InnoFluidics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on InnoFluidics.

Explore the full profile